Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of
PROLOR Biotech, Inc. Shareholders
NEW YORK -- April 25, 2013
Kirby McInerney LLP is investigating potential claims against the Board of
Directors of PROLOR Biotech, Inc. (“PROLOR” or the “Company”) (NYSE: PBTH)
related to the proposed acquisition of the Company by OPKO Health, Inc.
(“OPKO”) (NYSE: OPK). Under the terms of the proposal, PROLOR shareholders
will receive 0.9951 shares of OPKO common stock for each share of PROLOR
common stock. In total, the transaction is valued at approximately $480
million, or $7.00 per share of PROLOR common stock.
The investigation concerns whether the PROLOR Board of Directors violated its
fiduciary duties by agreeing to this transaction and whether the proposed
$7.00 per share consideration adequately values PROLOR common shares.
If you are a PROLOR shareholder and wish to obtain additional information,
please contact J.Brandon Walker, Esq. by email at firstname.lastname@example.org, or by
telephone at (212) 699-1145 or (888) 529-4787.
Kirby McInerney LLP is a New York-based law firm concentrating in securities,
shareholder, whistleblower, antitrust and consumer litigation. For additional
information, please go to www.kmllp.com.
Kirby McInerney LLP
J.Brandon Walker, Esq., 212-699-1145 or 888-529-4787
Press spacebar to pause and continue. Press esc to stop.